Cointime

Kinoxis Therapeutics

company

About

Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.

  • 1 - 10

Highlights

Total Funding Amount
$4.60M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$4.60M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Kinoxis Therapeutics is an early stage biotechnology company based in Australia that is working to progress the development of a range of novel therapeutic compounds for the treatment of substance use disorders and other CNS conditions. The company has licensed these compounds from the University of Sydney, with the lead candidate demonstrating potent anti-addictive and prosocial effects in a number of different animal models and is progressing through pre-clinical testing.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$4.60M
Kinoxis Therapeutics has raised a total of $4.60M in funding over 2 rounds. Their latest funding was raised on Sep 29, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 29, 2019 Grant $4.60M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Kinoxis Therapeutics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health — Grant
Cointime
เนื้อหา
บริษัท